Replies to post #253210 on Amarin Corp Plc (AMRN)

[couldbebetter]

Mr. Murphy, Up to this point AMRN has not announced anything about
accepting an offer for AMRN, or rejecting one for that matter. I do
know that JT has indicated if an offer were made he would do what is
in the best interest of shareholders. I maintain that at the right
price (hopefully there is one) JT will do what is best not only for
shareholders but also for patients who would benefit from a much
wider uptake of Vascepa once the BP sales reps begin detailing
Vascepa to their clientele.

[ak777]

james - I am sure there has been a reset of expectations re. BO valuations for prospective bios in general. for us, in terms of possible BO this means:

1. BO price will be lower than earlier expectations of some many on this board (eg. biobillionaire with his mega-SP prediction).

1. Likelihood of BO becomes greater; I say this because a lower BO price is more appetizing and easier for a BP to justify from a BO valuation perspective - if instead of paying 44/share, you negotiate a 38/share price due to market conditions, it makes your consideration much more serious given the same revenue projections